Past oral contraceptive and hormone therapy use and endogenous hormone concentrations in postmenopausal women

被引:26
|
作者
Chan, Mei-Fen [1 ]
Dowsett, Mitch [2 ]
Folkerd, Elizabeth [2 ]
Wareham, Nicholas [3 ]
Luben, Robert [1 ]
Welch, Ailsa [1 ]
Bingham, Sheila [4 ]
Khaw, Kay-Tee [1 ]
机构
[1] Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Clin Gerontol Unit,Dept Publ Hlth & Primary Care, Cambridge CB2 2QQ, England
[2] Royal Marsden Hosp, Acad Dept Biochem, London SW3 6JJ, England
[3] MRC, Epidemiol Unit, Cambridge, England
[4] MRC, Dunn Human Nutr Unit, Cambridge, England
基金
英国医学研究理事会;
关键词
oral contraceptives; hormone therapy; sex hormones; testosterone; estradiol;
D O I
10.1097/gme.0b013e31806458d9
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: Exogenous sex hormone use is associated with many health effects. Current exogenous hormone use influences endogenous sex hormone levels, but little is known about longer term effects on endogenous hormones after cessation of use. The aim of this study was to examine the relationship between past hormone use and current endogenous hormone status. Design: This was a cross-sectional study of 1,983 postmenopausal women aged 55 to 81 years from the general community. The women were not currently using exogenous hormones. Past use of oral contraceptives (OCs) and hormone therapy (HT) as well as circulating endogenous sex hormones and sex hormone-binding globulin concentrations were evaluated. Results: Past OC users had significantly lower endogenous estradiol, estrone, androstenedione, testosterone, and sex hormone-binding globulin concentrations compared with never users independent of age, body mass index, smoking, physical activity, and reproductive factors. Past HT users had significantly lower testosterone and 17 alpha-hydroxyprogesterone concentrations. Past OC use and HT use were both independently associated with lower testosterone concentrations: - 9% (95% CI: - 16% to - 2%) for ever OC use compared with never OC use and -7% (95% CI: -17% to -2%) for ever HT use compared with never HT use. The magnitude of 5% to 10% differences in endogenous hormone concentrations was similar or greater for past OC use compared with past HT use, although OC use occurred earlier in the past. Conclusions: Past OC use and HT use seem to be related to long-term differences in endogenous sex hormones and sex hormone-binding globulin concentrations in postmenopausal women many years after cessation of use. These findings have implications for understanding the longer term effects of exogenous hormone exposures earlier in life with health and disease risk in later life.
引用
收藏
页码:332 / 339
页数:8
相关论文
共 50 条
  • [1] Combined effect of oral contraceptive use and hormone replacement therapy on breast cancer risk in postmenopausal women
    Norman, SA
    Berlin, JA
    Weber, AL
    Strom, BL
    Daling, JR
    Weiss, LK
    Marchbanks, PA
    Bernstein, L
    Voigt, LF
    McDonald, JA
    Ursin, G
    Liff, JM
    Burkman, RT
    Malone, KE
    Simon, MS
    Folger, SG
    Deapen, D
    Wingo, PA
    Spirtas, R
    [J]. CANCER CAUSES & CONTROL, 2003, 14 (10) : 933 - 943
  • [2] Combined effect of oral contraceptive use and hormone replacement therapy on breast cancer risk in postmenopausal women
    Sandra A. Norman
    Jesse A. Berlin
    Anita L. Weber
    Brian L. Strom
    Janet R. Daling
    Linda K. Weiss
    Polly A. Marchbanks
    Leslie Bernstein
    Lynda F. Voigt
    Jill A. McDonald
    Giske Ursin
    Jonathan M. Liff
    Ronald T. Burkman
    Kathleen E. Malone
    Michael S. Simon
    Suzanne G. Folger
    Dennis Deapen
    Phyllis A. Wingo
    Robert Spirtas
    [J]. Cancer Causes & Control, 2003, 14 : 933 - 943
  • [3] Previous oral contraceptive use and breast cancer risk according to hormone replacement therapy use among postmenopausal women
    Dumeaux, V
    Fournier, A
    Lund, E
    Clavel-Chapelon, F
    [J]. CANCER CAUSES & CONTROL, 2005, 16 (05) : 537 - 544
  • [4] Previous oral contraceptive use and breast cancer risk according to hormone replacement therapy use among postmenopausal women
    Vanessa Dumeaux
    Agnès Fournier
    Eiliv Lund
    Françoise Clavel-Chapelon
    [J]. Cancer Causes & Control, 2005, 16 : 537 - 544
  • [5] Flaxseed consumption influences endogenous hormone concentrations in postmenopausal women
    Hutchins, AM
    Martini, MC
    Olson, BA
    Thomas, W
    Slavin, JL
    [J]. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2001, 39 (01): : 58 - 65
  • [6] Oral contraceptive use and postmenopausal sex steroid hormone metabolism.
    Michels, Kara A.
    Coburn, Sally B.
    Anderson, Garnet
    Brinton, Louise A.
    Chen, Chu
    Falk, Roni T.
    Gass, Margery L.
    Geczik, Ashley M.
    Manson, Joann E.
    Pfeiffer, Ruth M.
    Reding, Kerryn
    Sarto, Gloria E.
    Wentzensen, Nicolas
    Wild, Robert A.
    Xu, Xia
    Trabert, Britton
    [J]. CLINICAL CANCER RESEARCH, 2021, 27 (03)
  • [7] Past exogenous hormone use and current endogenous sex hormone status in postmenopausal women in the EPIC-Norfolk population cohort
    Chan, MF
    Khaw, KT
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S248 - S249
  • [8] Oral contraceptive and hormone replacement therapy in women with cerebral aneurysms
    Chen, Michael
    Ouyang, Bichun
    Goldstein-Smith, Lindsay
    Feldman, Lisa
    [J]. JOURNAL OF NEUROINTERVENTIONAL SURGERY, 2011, 3 (02) : 163 - 166
  • [9] The effect of hormone replacement therapy, previous oral contraceptive use and lifetime estrogen and progestin exposure on intraocular pressure in postmenopausal women
    Abramov, Y
    Borik, S
    Yahalom, C
    Fatum, M
    Avgil, G
    Brzezinsky, A
    Banin, E
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2003, 10 (06): : 577 - 577
  • [10] Analgesic Use and Sex Steroid Hormone Concentrations in Postmenopausal Women
    Gates, Margaret A.
    Tworoger, Shelley S.
    Eliassen, A. Heather
    Missmer, Stacey A.
    Hankinson, Susan E.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (04) : 1033 - 1041